Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator

Journal of Vascular and Interventional Radiology

Volumn 7, Issue 6, 1996, Pages 845-851

  Chang, Richard ^a   Horne III, McDonald K ^b   Mayo, Donna Jo ^b   Doppman, John L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Thrombolysis; Thrombosis, venous; Tissue type plasminogen activator; Veins, jugular, 907.1265; Veins, subclavian, 9462.1265

Indexed keywords

PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CATHETERIZATION; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; JUGULAR VEIN; MALE; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; SUBCLAVIAN VEIN; THROMBOSIS; TIME; VASCULAR PATENCY;

ADULT; AGED; CATHETERIZATION, PERIPHERAL; FEMALE; HUMANS; JUGULAR VEINS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; SUBCLAVIAN VEIN; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR PATENCY;

EID: 0030280715     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(96)70858-8     Document Type: Article

References (21)

1. Horattas MC, Wright DJ, Fenton AH, et al. Changing concepts of deep venous thrombosis of upper extremity: report of a series and review of the literature. Surgery 1988; 104:561-567.
2. Hill SL, Berry RE. Subclavian vein thrombosis: a continuing challenge. Surgery 1990; 108:1-9.
3. Fraschini G, Jadeja J, Lawson M, et al. Local infusions of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol 1987; 5:672-678.
4. Reed JD, Harman JT, Harris V. Regional fibrinolytic therapy for iatrogenic subclavian vein thrombosis. Semin Intervent Radiol 1992; 9:183-189.
5. Seigel EL, Jew AC, Delcore R, Iliopoulos JI, Thomas JH. Thrombolytic therapy for catheter-related thrombosis. Am J Surg 1993; 166: 716-719.
6. Keaney JF, Loscalzo J. Pharmacology of thrombolytic agents. In: Loscalzo J, Schafer AI, eds. Thrombosis and hemorrhage. Boston, MA: Blackwell Scientific Publications, 1994; 1173-1206.
7. Bookstein JJ, Valji K. Pulse-spray pharmacomechanical thrombolysis. Cardiovasc Intervent Radiol 1992; 15:228-233.
8. Agnelli G. Rationale for bolus t-PA therapy to improve efficacy and safety. Chest 1990; 97:1618-1673.
9. Goldhaber SZ, Agnelli G, Levine MN. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. Chest 1994; 106:718-724.
10. Bang NU, Wilhelm OG, Clayman MD. Coronary thrombolysis and reperfusion: literature review and future projections. Semin Intervent Radiol 1992; 9:195-207.
11. Diamond SL, Anand S. Inner clot diffusion and permeation during fibrinolysis. Biophys J 1993; 65: 2622-2643.
12. Tilney NL, Griffiths HJG, Edwards EA. Natural history of major venous thrombosis of the upper extremity. Arch Surg 1970; 101: 792-796.
13. Aburahma AF, Robinson PA, Sadler DL. Axillary-subclavian vein thrombosis. Am Surg 1991; 57:101-107.
14. Adams JT, McEvoy RK, DeWeese JA. Primary deep venous thrombosis of the upper extremity. Arch Surg 1965; 91:29-42.
15. Zimmerman R, Morl H, Harenberg J, et al. Urokinase therapy of subclavian-axillary vein thrombosis. Klin Wochenschr 1981; 59:851-856.
16. Gaffney PJ. D-dimer: history of the discovery, characterization and utility of this and other fibrin fragments. Fibrinolysis 1993; 7(suppl 2):2-8.
17. Scharfstein JS, Gold HK, Loscalzo J. New antithrombotic strategies. In: Loscalzo J, Schafer AI, eds. Thrombosis and hemorrhage. Boston, MA: Blackwell Scientific Publications, 1994; 1207-1223.
18. Weitz JI, Hudoba M, Massel DM, et al. Clot bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86:385-391.
19. Mirshahi M, Soria J, Soria C, et al. Evaluation of the inhibition by heparin and hirudin of coagulation activation during rtPA-induced thrombolysis. Blood 1989; 74:1025-1030.
20. Becker GJ, Rabe FE, Richmond BD, et al. Lose-dose fibrinolytic therapy. Radiology 1983; 148:663-670.
21. Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992; 326:975-982.